New approaches to the prevention of childhood atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 1, 2014, Pages 56-61

  Flohr, C ^a   Mann, J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

atopic dermatitis; atopic eczema; eczema; prevention

Indexed keywords

FOOD ALLERGEN; PREBIOTIC AGENT; PROBIOTIC AGENT;

ATOPIC DERMATITIS; CHILDHOOD DISEASE; DERMATOPHAGOIDES; DIET SUPPLEMENTATION; FEEDING BEHAVIOR; HUMAN; INFANT FEEDING; INTESTINE FLORA; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SKIN BARRIER; SKIN INFECTION; SKIN PERMEABILITY; WATER HARDNESS;

ATOPIC DERMATITIS; ATOPIC ECZEMA; ECZEMA; PREVENTION;

ANIMALS; CHILD; DERMATITIS, ATOPIC; HUMANS;

EID: 84892705136     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12343     Document Type: Review

References (74)

1. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103 (1 Pt 1): 125-138.
2. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR,. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121: 947-954.
3. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A,. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS ONE 2012; 7: e39803.
4. Kemp AS,. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003; 21: 105-113.
5. Mancini AJ, Kaulback K, Chamlin SL,. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25: 1-6.
6. Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F,. The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 2002; 147: 716-724.
7. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199.
8. Arnold RJ, Donnelly A, Altieri L, Wong KS, Sung J,. Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis. Manag Care Interface 2007; 20: 18-23.
9. Lewis-Jones S,. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984-992.
10. Meltzer LJ, Moore M,. Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. J Pediatr Psychol 2008; 33: 279-291.
11. Misery L, Finlay AY, Martin N, Boussetta S, Nguyen C, Myon E, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology 2007; 215: 123-129.
12. Schmitt J, Apfelbacher C, Chen CM, Romanos M, Sausenthaler S, Koletzko S, et al. Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 2010; 125: 404-410.
13. Weisshaar E, Diepgen TL, Bruckner T, Fartasch M, Kupfer J, Lob-Corzilius T, et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008; 88: 234-239.
14. Flohr C,. Recent perspectives on the global epidemiology of childhood eczema. Allergol Immunopathol (Madr) 2011; 39: 174-182.
15. Flohr C, Mann J,. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014; 69: 3-16.
16. Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC,. Overview of reviews the prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6: 1322-1339.
17. Snijders BEP, Thijs C, van Ree R, van den Brandt PA,. Age at first introduction of cow milk products and other food products in relation to infant atopic manifestations in the first 2 years of life: the KOALA Birth Cohort Study. Pediatrics 2008; 122: e115-e122.
18. Sariachvili M, Droste J, Dom S, Wieringa M, Hagendorens M, Stevens W, et al. Early exposure to solid foods and the development of eczema in children up to 4 years of age. Pediatr Allergy Immunol 2010; 21 (1 Pt 1): 74-81.
19. Flohr C, Nagel G, Weinmayr G, Kleiner A, Strachan DP, Williams HC, et al. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2011; 165: 1280-1289.
20. Roduit C, Frei R, Loss G, Buchele G, Weber J, Depner M, et al. Development of atopic dermatitis according to age of onset and association with early-life exposures. J Allergy Clin Immunol 2012; 130: 130-136.
21. Filipiak B, Zutavern A, Koletzko S, von Berg A, Brockow I, Grubl A, et al. Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. J Pediatr 2007; 151: 352-358.
22. Zutavern A, Brockow I, Schaaf B, von Berg A, Diez U, Borte M, et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics 2008; 121: e44-e52.
23. COMA Working Group. Weaning and the Weaning Diet. London: COMA Working Group, 2004.
24. Burr ML, Butland BK, King S, Vaughan-Williams E,. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452-1456.
25. Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008; 122: 984-991.
26. von Berg A, Filipiak-Pittroff B, Kramer U, Link E, Bollrath C, Brockow I, et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121: 1442-1447.
27. von Berg A, Koletzko S, Filipiak-Pittroff B, Laubereau B, Grubl A, Wichmann H-E, et al. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007; 119: 718-725.
28. Alexander DD, Cabana MD,. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr 2010; 50: 422-430.
29. Osborn DA, Sinn J,. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2006; CD003664. doi: 10.1002/14651858.
30. von Berg A, Filipiak-Pittroff B, Kramer U, Hoffmann B, Link E, Beckmann C, et al. Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study. J Allergy Clin Immunol 2013; 131: 1565-1573.
31. Pfefferle PI, Prescott SL, Kopp M,. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J Allergy Clin Immunol 2013; 131: 1453-1463.
32. Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23: 402-414.
33. Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper. World Allergy Organ J 2012; 5: 148-167.
34. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E,. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
35. Lau S, Gerhold K, Zimmermann K, Ockeloen CW, Rossberg S, Wagner P, et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129: 1040-1047.
36. Arnedo-Pena A, Bellido-Blasco J, Puig-Barbera J, Artero-Civera A, Campos-Cruanes JB, Pac-Sa MR, et al. [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children]. Salud Publica Mex 2007; 49: 295-301.
37. Miyake Y, Yokoyama T, Yura A, Iki M, Shimizu T,. Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area. Environ Res 2004; 94: 33-37.
38. Osborn DA, Sinn JK,. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 2013; 3: CD006474.
39. Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E,. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012; 26 (Suppl 3): 49-59.
40. Hartmann B, Riedel R, Jorss K, Loddenkemper C, Steinmeyer A, Zugel U, et al. Vitamin D receptor activation improves allergen-triggered eczema in mice. J Invest Dermatol 2012; 132: 330-336.
41. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122: 829-831.
42. Wills AK, Shaheen SO, Granell R, Henderson AJ, Fraser WD, Lawlor DA,. Maternal 25-hydroxyvitamin D and its association with childhood atopic outcomes and lung function. Clin Exp Allergy 2013; 43: 1180-1188.
43. Jones AP, Palmer D, Zhang G, Prescott SL,. Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy. Pediatrics 2012; 130: e1128-e1135.
44. Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat 2011; 22: 144-150.
45. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr,. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol 2008; 159: 245-247.
46. Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC,. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev 2012; 2: CD005205.
47. Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S, et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS ONE 2013; 8: e66627.
48. Willers SM, Devereux G, Craig LC, McNeill G, Wijga AH, Abou El-Magd W, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 2007; 62: 773-779.
49. Sausenthaler S, Koletzko S, Schaaf B, Lehmann I, Borte M, Herbarth O, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. Am J Clin Nutr 2007; 85: 530-537.
50. Romieu I, Torrent M, Garcia-Esteban R, Ferrer C, Ribas-Fito N, Anto JM, et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clin Exp Allergy 2007; 37: 518-525.
51. Oien T, Storro O, Johnsen R,. Do early intake of fish and fish oil protect against eczema and doctor-diagnosed asthma at 2 years of age? A cohort study. J Epidemiol Community Health 2010; 64: 124-129.
52. Alm B, Aberg N, Erdes L, Mollborg P, Pettersson R, Norvenius SG, et al. Early introduction of fish decreases the risk of eczema in infants. Arch Dis Child 2009; 94: 11-15.
53. D'Vaz N, Meldrum SJ, Dunstan JA, Martino D, McCarthy S, Metcalfe J, et al. Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial. Pediatrics 2012; 130: 674-682.
54. Ring J, Darsow U, Behrendt H,. Role of aeroallergens in atopic eczema: proof of concept with the atopy patch test. J Am Acad Dermatol 2001; 45 (Suppl 1): S49-S52.
55. Schafer T,. The impact of allergy on atopic eczema from data from epidemiological studies. Curr Opin Allergy Clin Immunol 2008; 8: 418-422.
56. Garritsen FM, Ter Haar NM, Spuls PI,. House dust mite reduction in the management of atopic dermatitis. A critically appraised topic. Br J Dermatol 2013; 168: 688-691.
57. Gehring U, de Jongste JC, Kerkhof M, Oldewening M, Postma D, van Strien RT, et al. The 8-year follow-up of the PIAMA intervention study assessing the effect of mite-impermeable mattress covers. Allergy 2012; 67: 248-256.
58. Harris JM, Williams HC, White C, Moffat S, Mills P, Newman Taylor AJ, et al. Early allergen exposure and atopic eczema. Br J Dermatol 2007; 156: 698-704.
59. McNally NJ, Williams HC, Phillips DR, Smallman-Raynor M, Lewis S, Venn A, et al. Atopic eczema and domestic water hardness. Lancet 1998; 352: 527-531.
60. Chaumont A, Voisin C, Sardella A, Bernard A,. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. Environ Res 2012; 116: 52-57.
61. Thomas KS, Dean T, O'Leary C, Sach TH, Koller K, Frost A, et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med 2011; 8: e1000395.
62. Flohr C, England K, Radulovic S, McLean WH, Campbel LE, Barker J, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010; 163: 1333-1336.
63. Williams HC, Chalmers JR, Simpson EL,. Prevention of atopic dermatitis. F1000 Med Rep 2012; 4: 24.
64. Kim BE, Leung DY,. Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 2012; 4: 12-16.
65. Elias PM, Wakefield JS,. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 282-295.
66. Novak N, Simon D,. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
67. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC,. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2011; 164: 228.
68. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C,. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 2011; 164: 415-428.
69. Flohr C, Johansson SG, Wahlgren CF, Williams H,. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114: 150-158.
70. van den Oord RA, Sheikh A,. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339: b2433.
71. Tang TS, Bieber T, Williams HC,. Does "autoreactivity" play a role in atopic dermatitis? J Allergy Clin Immunol 2012; 129: 1209-1215.
72. Bieber T, Cork M, Reitamo S,. Atopic dermatitis: a candidate for disease-modifying strategy. Allergy 2012; 67: 969-975.
73. Eyerich K, Novak N,. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013; 68: 974-982.
74. Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67: 1111-1117.